Timothy A. Timmins serves as Executive at Entia Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Timothy A. Timmins has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 16, 2017 involved receiving (via award) 250,000 shares valued at $0.
Timothy A. Timmins currently holds 800,000 shares of Entia Biosciences, Inc. (ERGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy A. Timmins has been a net neutral trader of ERGO stock. They have purchased $0 and sold $0 worth of shares.
Timothy A. Timmins's most recent insider trade was on Feb 16, 2017, when they sold 250,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 14, 2017 | ERGO | $0 | Award | 300,000 | $N/A | Discretionary |